Literature DB >> 25669999

Decreased serum vitamin D levels in Japanese patients with multiple sclerosis.

Masaaki Niino1, Shinya Sato2, Toshiyuki Fukazawa3, Katsuhisa Masaki2, Yusei Miyazaki4, Dai Matsuse2, Ryo Yamasaki5, Eri Takahashi6, Seiji Kikuchi7, Jun-ichi Kira2.   

Abstract

Data regarding vitamin D in multiple sclerosis (MS) in Asia are limited. We investigated whether Japanese MS patients show decreased serum 25-hydroxyvitamin D [25(OH)D], 1,25-dihydroxyvitamin D [1,25(OH)2D], and vitamin D-binding protein (DBP) during winter. Mean serum 25(OH)D and 1,25(OH)2D levels were significantly lower in MS patients than in controls. There were no significant differences in serum 25(OH)D, 1,25(OH)2D, and DBP levels between patients or between controls from northern Japan (Hokkaido) and southern Japan (Kyushu). Serum vitamin D levels were low in Japanese MS patients but did not differ in patients from northern and southern Japan.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Multiple sclerosis; Progression; Severity; Vitamin D; Vitamin D-binding protein

Mesh:

Substances:

Year:  2015        PMID: 25669999     DOI: 10.1016/j.jneuroim.2015.01.007

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  7 in total

Review 1.  The Beneficial and Debilitating Effects of Environmental and Microbial Toxins, Drugs, Organic Solvents and Heavy Metals on the Onset and Progression of Multiple Sclerosis.

Authors:  Mahmood Y Hachim; Noha M Elemam; Azzam A Maghazachi
Journal:  Toxins (Basel)       Date:  2019-03-05       Impact factor: 4.546

2.  Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)2D, but No Difference in Ratio of 25(OH)D/24,25(OH)2D and FGF23 Concentrations.

Authors:  Mariska C Vlot; Laura Boekel; Jolijn Kragt; Joep Killestein; Barbara M van Amerongen; Robert de Jonge; Martin den Heijer; Annemieke C Heijboer
Journal:  Nutrients       Date:  2019-11-15       Impact factor: 5.717

3.  Vitamin D serum level in subjects with critical illness polyneuropathy and myopathy.

Authors:  Domenico Intiso; Andrea Fontana; Massimiliano Copetti; Luigi Amoruso; Michelangelo Bartolo; Andrea Santamato; Filomena Di Rienzo
Journal:  J Musculoskelet Neuronal Interact       Date:  2020-03-03       Impact factor: 2.041

4.  Serum Vitamin D Levels and Status in Thai Optic Neuritis Subjects: A Case-Control Study.

Authors:  Busayanut Puangsricharoen; Kavin Vanikieti; Panitha Jindahra; Tanyatuth Padungkiatsagul
Journal:  Clin Ophthalmol       Date:  2022-10-12

5.  Free vitamin D3 index and vitamin D-binding protein in multiple sclerosis: A presymptomatic case-control study.

Authors:  Viktor Grut; Martin Biström; Jonatan Salzer; Pernilla Stridh; Anna Lindam; Lucia Alonso-Magdalena; Oluf Andersen; Daniel Jons; Martin Gunnarsson; Magnus Vrethem; Johan Hultdin; Peter Sundström
Journal:  Eur J Neurol       Date:  2022-06-04       Impact factor: 6.288

6.  Remission of Severe Myasthenia Gravis After Massive-Dose Vitamin D Treatment.

Authors:  Flávio Adsuara Cadegiani
Journal:  Am J Case Rep       Date:  2016-01-29

7.  Environmental Risk Factors for Multiple Sclerosis: A Case-control Study in Kerman, Iran.

Authors:  Mahlagha Dehghan; Fatemeh Ghaedi-Heidari
Journal:  Iran J Nurs Midwifery Res       Date:  2018 Nov-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.